Pharminent

Sanofi to invest further in biologics

PARIS (Reuters) – Sanofi announced plans to invest 600 million euros ($673 million) annually over the next two to three years in the field of biologics production, an area of strong growth potential.

http://www.reuters.com/article/us-sanofi-biologics-idUSKBN1951IV

Filed under: Company